OA-29 Mezigdomide (MEZI), Tazemetostat (TAZ), and Dexamethasone (DEX) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results From the CA057-003 Trial
Year: 2024
Type: conference-abstract
Authors: Luciano Costa, Rakesh Popat, David Siegel, Fredrik Schjesvold, Saad Usmani, Nizar J. Bahlis, Albert Oriol, Michael Chu, Syed Abbas Ali, Karthik Ramasamy, Monique Hartley-Brown, Joaquín Martínez-Lopez, Allison Gaudy, Antonina Kurtova, Wen Zhang, Rafael Sarmiento, August Dietrich, Jessica Katz, Michael Pourdehnad, Paul Richardson
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402735822